Morgan CJ, Gardener C, Schafer G, Swan S, Demarchi C, Freeman TP, Warrington P, Rupasinghe I, Ramoutar A, Tan N, Wingham G, Lewis S, Curran HV, (in press) Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychological Medicine.

Morgan CJ and Curran HV (in press). Ketamine use: a review. Addiction.

Freeman TP, Morgan CJA, Beesley T, Curran HV (in press). Drug-cue induced overshadowing: selective disruption of natural reward processing by cigarette cues amongst abstinent but not satiated smokers. Psychological Medicine.

Kamboj SK, Massey-Chase R, Rodney L, Das R, Almahdi B, Curran H, Morgan CJ (in press) Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of D-cycloserine in heavy drinkers. Psychopharmacology.

Back to top


Carroll EM, Kamboj SK, Conroy L, Tookman A, Williams AC, Jones L, Morgan CJ, Curran HV (2011) Facial Affect Processing in Patients Receiving Opioid Treatment in Palliative Care: Preferential Processing of Threat in Pain Catastrophizers. J Pain Symptom Manage, 41, 975-985.

Tai YF, Hoshi R, Brignell CM, Cohen L, Brooks DJ, Piccini P (2011) Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMD ('Ecstasy'): An (18)F-Dopa PET study. Neuropsychopharmacology, 36, 735-743.

Back to top


Platt B, Kamboj S, Morgan CJA, Curran HV (2010) Processing dynamic facial affect in frequent cannabis-users: Evidence of deficits in the speed of identifying emotional expressions. Drug and Alcohol Dependence, 112, 27-32.

Curran HV, Freeman TP, Schafer GL, Morgan CJA (2010) Does cannabidiol protect against the harms of THC? British Journal of Psychiatry.

Morgan CJA, Schafer G, Freeman TP, Curran HV (2010) Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: a naturalistic study. British Journal of Psychiatry, 197, 285-90.

Constantinou N, Morgan CJA, Battista S, O'Ryan D, Davis P, Curran HV (2010) Attentional bias, inhibitory control and acute stress in current and former opiate addicts. Drug and Alcohol Dependence, 109, 220-5.

Morgan CJA, Freeman TP, Schafer GL, Curran HV (2010) Cannabidiol Attenuates the Appetitive Effects of Delta(9)-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis. Neuropsychopharmacology, 35, 1879-85.

Bisby JA, King JA, Brewin CR, Burgess N, Curran HV (2010) Acute effects of alcohol on intrusive memory development and viewpoint dependence in spatial memory support a dual representation model. Biological Psychiatry, 68, 280-286.

Brown J, Brignell CM, Dhiman SK, Curran HV, Kamboj SK (2010) Acute effects of alcohol on memory: Impact of emotional context and serial position. Neurobiology of Learning and Memory, 93, 428-34.

Morgan CJA, Rothwell E, Atkinson H, Mason O, Curran HV (2010) Hyper-priming in cannabis users: a naturalistic study of the effects of cannabis on semantic memory function. Psychiatry Research, 176, 231-8.

Morgan CJA, Muetzelfeldt L, Muetzelfeldt M, Nutt DJ, Curran HV (2010) Harms associated with psychoactive substances: findings of the UK National Drug Survey. Journal of Psychopharmacology,24, 147-153.

Paraskevaides T, Morgan CJA, Leitz JR, Bisby JA, Rendell PG, Curran HV (2010) Drinking and future thinking: acute effects of alcohol on prospective memory and future simulation. Psychopharmacology, 208, 301-308.

Morgan CJA, Muetzelfeldt L, Curran HV (2010) Consequences of chronic ketamine self-administration upon neurocognitive function and psychological well-being: a 1 year longitudinal study. Addiction, 105, 121-133.

Bisby JA, Leitz JR, Morgan CJA, Curran, HV (2010) Decreases in recollective experience following acute alcohol: a dose-response study. Psychopharmacology, 208, 67-74.


Curran HV, D'Souza DC, Robbins TW, Fletcher, P (2009) Modelling Psychosis. Psychopharmacology, 206, 513-514.

Freeman TP, Morgan CJA, Klaasen E, Das RK, Stefanovic A, Brandner B, Curran HV (2009) Superstitious conditioning as a model of delusion formation following chronic but not acute ketamine in humans. Psychopharmacology, 206, 563-573.

Stokes PRA, Mehta MA, Curran HV, Breen G, Grasby PM (2009) Can recreational doses of THC produce significant dopamine release in the human striatum? NeuroImage, 48, 186-190.

Pine A, Seymour B, Roiser JP, Bossaerts P, Friston KJ, Curran HV, Dolan RJ (2009) Encoding of marginal utility across time in the human brain. Journal of Neuroscience, 29, 9575-9581.

Leitz JR, Morgan CJA, Bisby JA, Rendell PG, Curran HV (2009) Global impairments of Prospective Memory following Acute Alcohol. Psychopharmacology, 205, 379-387.

Whiteley C, Wanigaratne S, Marshall J, Curran HV (2009) Autobiographical memory in recently detoxified dependent drinkers. Alcohol and Alcoholism, 44, 429-430.

Morgan CJA, Huddy VJ, Baker M, Curran HV, Joyce EM (2009) Is persistent ketamine use a valid model of cognitive and oculomotor deficits in schizophrenia? Biological Psychiatry, 65, 1099-1102.

Bisby JA, Brewin CR, Leitz JR, Curran HV (2009) Acute effects of alcohol on the development of intrusive memories. Psychopharmacology, 204, 655-666.

Mason O, Morgan CJA, Dhiman SK, Patel A, Parti N, Patel A, Curran HV (2009) Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis. Psychological Medicine, 39, 951-956.

Clair J, Martin L, Bond AJ, O’Ryan D, Davis P & Curran HV (2009) An experimental study of aggressive and neutral interpretative bias in opiate-dependent and opiate-abstinent men. Journal of Psychopharmacology, 23, 428-435.

Selvaraj S, Hoshi R, Bhagwager Z, Murthy NV, Hinz R, Cowen P, Curran HV & Grasby P (2009) Brain serotonin transporter binding in former users of MDMA ('ecstasy'). The British Journal of Psychiatry, 194, 355-359.

Stefanovic A, Brandner B, Klassen E, Cregg R, Nagaratnam M, Bromley L, Das RK, Rossell SL, Morgan CJA, Curran HV (2009) Acute and Chronic Effects of Ketamine on Semantic Priming: Modelling Schizophrenia? Journal of Clinical Psychopharmacology, 29, 124-33.

Morgan CJA, Muetzelfeldt L, Curran HV (2009) Ketamine use, cognition and psychological well-being: a comparison of frequent, infrequent and ex users with polydrug and non-using controls. Addiction 104 (1), 77-87.

Blagrove M, Morgan CJA, Curran HV, Bromley L, Brandner B (2009) The incidence of unpleasant dreams after sub-anaesthetic ketamine. Psychopharmacology 203, 109-120.

Back to top


Morgan CJA, Rees H, Curran HV (2008). Attentional bias to incentive stimuli in frequent ketamine users. Psychological Medicine 38, 1331-40.

Mason OJ, Morgan CJM, Stefanovic A, Curran HV (2008). The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research 103, 138-42.

Friswell J, Phillips C, Holding J, Morgan CJA, Brandner B, Curran HV (2008). Acute effects of opioids on memory functions of healthy men and women. Psychopharmacology 198(2), 243-250.

Morgan CJA & Curran HV (2008). Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. British Journal of Psychiatry 192, 306-307.

Muetzelfeldt L, Kamboj S, Rees H, Taylor J, Morgan CJA & Curran HV (2008). Journey through the K-hole: phenomenological aspects of ketamine use. Drug and Alcohol Dependence 95(3), 219-229.

Back to top


Curran HV, Rees H, Morgan CJA (2007). Chronic effects of ketamine on cognitive function.The World Journal of Biological Psychiatry. Supplement 1(8), 95-95.

Curran HV, Whitty A, Morgan CJA, Henry J (2007). Cognitive and subjective effects of the acute MDMA both alone and in combination with alcohol. The World Journal of Biological Psychiatry Supplement 1(8), 96-96.

Hoshi R, Cohen L, Lumanski L, Piccini P, Bond A, Curran HV (2007). Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current- and ex-ecstasy users with polydrug- and drug naïve-controls. Experimental and Clinical Psychopharmacology 15(4), 351-358.

Hoshi R, Mullins K, Boundy C, Brignell C, Piccini P, Curran HV (2007). Neurocognitive function in current and ex users of ecstasy in comparison to both matched poly-drug using controls and drug-naïve controls. Psychopharmacology 194(3), 371-379.

Morgan CJA, Muetzelfeldt L, Rees H, Curran HV (2007). Attentional bias to incentive stimuli in heavy ketamine users. Journal of Psychopharmacology 21; A30.

Morgan CJA, Muetzelfeldt L, Rees H, Curran HV (2007). Frequent ketamine use impairs cognitive function. Journal of Psychopharmacology 21; A30.

Morgan CJA, Rees H, Curran HV (2007). Chronic schizophrenic and dissociative symptoms associated with ketamine abuse. The World Journal of Biological Psychiatry supplement 1(8), 94-94.

Muetzelfeldt L, Morgan CJA, Curran HV (2007). The subjective effects of ketamine: a longitudinal study. Journal of Psychopharmacology 21; A29.

Stokes PRA, Curran HV, Grasby PM (2007) . Does delta-9-THC produce dopamine release in the human striatum? Preliminary results from an 11C-raclopride PET study. Journal of Psychopharmacology 21; A54.

Ulhaas PJ, Curran HV, Millard I, Muetzelfeldt L, Morgan CJA (2007). Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later. Journal of Psychopharmacology 21(3), 347-352.

Back to top


Brignell CM and Curran HV (2006). Drugs, sweat and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning. Psychopharmacology 186(4), 504-516.

Curran HV (2006). Effects of drugs on witness memory. Chapter 5 in Heaton-Armstrong A, Shepherd E, Gudjonsson G, Wolchover D (ed.) Witness Testimony: Psychological, Investigative and Evidential Perspectives. Oxford University Press, 77-87.

Curran HV & Mintzer MZ (2006). Psychopharmacology of memory. Psychopharmacology 118(4), 393-396.

Curran HV and Robjant K (2006). Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy. Journal of Psychopharmacology 20(3), 425-431.

Hoshi R, Pratt H, Mehta S, Bond AJ and Curran HV (2006). An investigation into the sub-acute effects of ecstasy on aggressive interpretive bias and aggressive mood – are there gender differences? Journal of Psychopharmacology 20(2), 291-301.

Kamboj S, Curran HV (2006). Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust. Psychopharmacology 185(4), 529-535.

Kamboj SK, Curran HV (2006). Neutral and emotional episodic memory: global impairment after lorazepam and scopolamine. Psychopharmacology 188(4), 482-488.

Martin L, Clair J, Davis P, O’Ryan D, Hoshi R and Curran HV (2006). Enhanced recognition of facial expressions of disgust in opiate users receiving maintenance treatment. Addiction 101(11), 1598-1605.

Morgan CJA & Curran HV (2006). Acute & chronic effects of ketamine upon human memory: a review. Psychopharmacology 188(4), 408-424.

Morgan CJA, Mashru A, Jones B and Curran HV (2006). Self-referrant encoding and levels of processing in ketamine users. Journal of Psychopharmacology 20, A53, TB22.

Morgan CJA, Rossell S, Pepper F, Smart J , Blackburn J, Brandner B, Curran HV (2006). Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry 59(3), 265-272.

Pine A, Curran N, Brandner B, Morgan CJA, Rogers RD & Curran HV (2006). Selective effects of ketamine on regions subserved by the frontal cortex. Journal of Psychopharmacology 20, A52, TB21.

Rees HM, Morgan CJA and Curran HV (2006). Delusional symptoms in ketamine users. Journal of Psychopharmacology 20, A53, TB23.

Rossell S, Curran HV, Morgan CJA (2006). Using ketamine to model thought disorder in schizophrenia. Acta Neuropsychiatrica 18(6), 268-269.

Shanks DR, Channon S, Wilkinson L, Curran HV (2006). Disruption of sequential priming in organic and pharmacological amnesia: a role for the medial temporal lobes in implicit contextual learning. Neuropsychopharmacology 31(8), 1768-1776.

Back to top


Curran HV and Drummond C (2005). State of Science Review: Psychological Treatments for substance misuse and dependence.

Curran HV, Whitty A and Henry JA (2005). The acute cognitive and subjective effects of MDMA alone and in combination with alcohol. Journal of Psychopharmacology 19, A25.

Kamboj SK, Tookman A, Jones L, Curran HV (2005). The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 117(3), 388-395.

Morgan CJA, Lippett R, Pepper F, Blackburn J, Brandner,B and Curran HV (2005). ‘Me-pulse’ inhibition: a novel self-monitoring task piloted in high schizotypy scorers, healthy volunteers following an acute dose of ketamine and ketamine users. Journal of Psychopharmacology 19, A14, A56.

Back to top


Bond AJ, Verheyden SL, Wingrove J, Curran HV (2004). Angry cognitive bias and trait aggression and impulsivity in substance users. Psychopharmacology 171, 331-339. ISSN: 0033-3158.

Curran HV, Kopelman M, Rusted JM (2004). The psychopharmacology of Alzheimer's Disease. in Morris.R. & Ed (ed.) The Cognitive Neuropsychology of Alzheimer-type Dementia. Oxford University Press, 321-353.

Curran HV, Rees H, Hoare T, Hoshi R, Bond AJ (2004). Empathy and aggression: two faces of ecstasy? A study of interpretative bias and mood change in ecstasy users. Psychopharmacology 173, 425-433. ISSN: 0033-3158.

Hoshi R, Bisla J, Curran HV (2004). The acute and sub-acute effects of ecstasy (MDMA) on processing of facial expressions: preliminary findings. Drug and Alcohol Dependence 76, 297-304.

Hoshi R, Curran HV (2004). Acute ecstasy administration affects the processing of fearful facial expressions. Journal of Psychopharmacology 18, A38.

Kamboj K, Tookman A, Jones L, Curran HV (2004). Retrograde and anterograde memory impairment following breakthrough morphine in patients receiving palliative care. Journal of Psycopharmacology 18, A42.

Iliffe S, Curran HV, Collins R, Yuen Kee SC, Fletcher S, Woods RT (2004). Attitudes to a long-term use of Benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Ageing and Mental Health 8, 243-249.

Morgan CJA, Mofeez A, Brandner B, Bromley L, Curran HV (2004). Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29(1), 208-218.

Morgan CJA, Mofeez A, Brandner B, Bromley L, Curran HV (2004). Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose response study. Psychopharmacology 172, 298-308.

Morgan CJA, Pepper F, Smart J, Curran HV (2004). Semantic priming following acute and chronic ketamine. Journal of Psychopharmacology 18, A53.

Morgan CJM, Monaghan L, Curran HV (2004). Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction 99, 1450-1461.

Morgan CJA, Riccelli M, Maitland CH, Curran HV (2004). Long-term effectsof ketamine abuse: evidence of persisting impairment of source memory in recreational users. Drug and Alcohol Dependence 75, 301-308.

Smart JA, Morgan CJA, Curran HV, Bromley L & Brandner B (2004). Ketamine and temporal summation. Anesthesiology 101; A1143.

Zangara A, Curran HV (2004). Tranquilising emotional memories: Acute effects of metoprolol, diazepam and placebo in healthy volunteers. Proceedings of the British Psychological Society, 12 (4).

Back to top


Curran HV, Collins R, Fletcher S, Chin Yuen Kee S, Woods RT, Iliffe S (2003). Withdrawal of older adults from benzodiazepine hypnotics in General Practice: effects on cognitive function, sleep, mood and quality of life. Journal of Psychopharmacology 17.

Curran HV, Collins R, Fletcher S, Yuen Kee SC, Woods RT, Iliffe S (2003). Older adults and withdrawal from benzodiazepine hypnotics in General Practice: effects on cognitive function, sleep, mood and quality of life. Psychological Medicine 33(7), 1223-1237.

Curran HV, Verheyden SL (2003). Altered response to tryptophan supplementation after long-term abstention from MDMA ("Ecstasy") is highly correlated with human memory function. Psychopharmacology 169(1), 91-103.

Hoshi R, Rees H, Hoare T, Bond A, Curran HV (2003). Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Journal of Psychopharmacology 17

Morgan CJA, Mofeez A, Brandner B, Bromley L, Curran HV (2003). Human memory systems and ketamine. Journal of Psychopharmacology 17

Morgan CJA, Ricelli M, Curran HV (2003). Lost in the K-hole: Persisting impairment of source memory in chronic ketamine abusers. Journal of Psychopharmacology 17

Richardson M, Powell,JH, Curran HV (2003). Investigating the influence of smoking on willed action and cognitive function in individuals with brain injury. Neuropsychological Rehabilitation 13, 365-378. ISSN: 0960-2011.

Verheyden S, Henry J, Curran HV (2003). Acute, sub-acute and long-term subjective consequences of ecstasy (MDMA) consumption in 430 regular users. Human Psychopharmacology 18, 1-11.

Verheyden S, Maidment R, Curran HV (2003). Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health. Journal of Psychopharmacology 17, 371-378.

Back to top


Blair RJR, Curran HV, Maratos E, Berthoz S, Morris J, Dolan RJ,& Mitchell RD (2002). A selective effect of diazepam on the neural response to angry, as opposed to fearful, expressions using event related fMRI. CNS.

Bond AJ, Wingrove J, Curran HV, Lader MH (2002). Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo. Journal of Affective Disorders 72, 267-271.

Brignell C, Curran,HV, Newman C, Richell R, Blair J (2002). A novel task to investigate the effect of á-blockade and benzodiazepines on memory for emotional material. Journal of Psychopharmacology, OT9, A69 and E9, A49.

Curran HV, Brignell C, Fletcher S, Middleton P, Henry J (2002). Cognitive and subjective dose-response effects of acute oral Ž9-tetrahydrocaccabinol (THC) in infrequent cannabis users. Psychopharmacology 164, 61-70.

Curran HV, Weingartner H (2002). Psychopharmacology of Memory. in Baddeley,A., Wilson,B., Kopelman,M. (ed.) The Handbook of Memory. New York: Wiley, 123-141.

Pompeia S, Rusted J.M , Curran,HV (2002). Verbal fluency facilitated by the cholinergic blocker, Scopolamine. Human Psychopharmacology: Clinical and Experimental 16, 1-9.

Verheyden S, Curran HV. (2002). SL Response to tryptophan after long-term abstention from 'ecstasy' is correlated with human memory function. Journal of Psychopharmacology, OT8, A69 and G8, A59.

Verheyden S, Hadfield J, Callin T, Curran,HV (2002). Sub-acute effects of. Psychopharmacology 161, 23-31.

Zangara A , Blair J, Curran HV (2002). Differential effects of a beta-blocker and a benzodiazepine on processing of emotional expressions. Psychopharmacology 163, 36-41.

Back to top


Curran HV , Kleckham J, Bearn J, Strang J, Wanagaratne S (2001). Effects of methadone on cognition mood and craving in detoxifying opiate addicts. Psychopharmacology 154, 153-160.

Curran HV, Monaghan L (2001). In and out of the K hole: a comparison of the acute and residual effects of ketamine in frequent & infrequent ketamine users. Addiction 96, 749-760.

Back to top


Brignell C, Fletcher S, Henry, JH, Curran HV (2000). Effects of D9 -Tetrahydrocannabinol (THC) on human memory systems. Journal of Psychopharmacology 14, A44.

Curran HV (2000). Is MDMA ('ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 42, 34-41.

Curran HV (2000). Psychopharmacological Approaches to Human Memory. in Gazzaniga,M. (ed.) The New Cognitive Neurosciences. Boston: MIT Press, 797-805.

Curran HV (2000). Benzodiazepines, memory and cognitive function. in Trimble M, Hindmarch, I. (ed.) Benzodiazepines. Hampshire: Wrightson Biomedical Publishers, 17-29.

Curran HV (2000). The psychopharmacology of Memory. in Tulving E, Craik, F (ed.) The Oxford Handbook of Memory. New York: Oxford University Press, 539-556.

Curran HV, Monaghan L (2000). In and out of the K hole: a comparison of the acute and residual effects of ketamine in frequent & infrequent ketamine users. Journal of Psychopharmacology 14, A12.

Curran HV, Morgan C (2000). Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and three days later. Addiction 95, 575-590.

Kleckham J, Curran HV, Bearn, J, Wanigaratne, S and Smyth C (2000) Cognitive and mood effects of methadone in detoxifying opiate addicts: a double-blind, dose-response study with in-patients. Journal of Psychopharmacology, 14, A16.

Milani R, Curran HV (2000) . Effects of a low dose alcohol on recollective experience of illusory memory. Psychopharmacology 147, 397-402.

Verheyden S, Curran HV (2000) . Tryptophan depletion and cognitive function in regular and ex-users of MDMA ('ecstasy'). Journal of Psychopharmacology 14; A13.

Zangara A, Curran HV (2000). Tranquilising emotional memories: acute effects of metaprolol, diazepam and placebo in healthy volunteers. Journal of Psychopharmacology 14; A43.

Back to top


Blair R , Curran HV (1999). Selective impairment in the recognition of anger induced by diazepam. Psychopharmacology 147 (3), 335-338.

Cilic G, Curran HV, Marks I (1999). A four year follow-up of agoraphobia with panic disorder: lack of residual effects of alprazolam on memory. Psychological Medicine 29, 225-231.

Curran HV (1999) The effects of anxiolytics on memory. Human Psychopharmacology: Clinical and Experimental, 14, S72-S79.

Curran HV , Bolton J, Wanagaratne S, Smyth C (1999) . Increased methadone dosage increases craving for opiates: a double-blind, placebo controlled study in chronic opiate users receiving methadone substitute treatement. Addiction 94, 665-674.

Curran HV, Hildebrandt M (1999) . Dissociative effects of alcohol on recollective experience. Consciousness and Cognition 8, 497-509.

Kapczinski F , Quevedo J , Curran HV, Fleminger S, Chuckie,A, Lader M (1999) . Brain uptake of benzodiazepines in cirrhotic patients: a single photon emission tomography study. Journal of Psychopharmacology 13, 219-225.

Kilic C, Curran, HV, Noshirvani,H, Marks IM, Basoglu,M (1999). Long-term effects of alprazolam on memory: A 3.5 year follow-up of agoraphobia/ panic patients. European Neuropsychopharmacology 6, 141; S4.

Back to top


Bishop K, Curran HV (1998). An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming. Psychopharmacology 140, 345-353.

Bolton J, Curran HV, Wanigaratne S, Smyth C (1998) . Increased craving for heroin following additional methadone in opiate addicts. Journal of Psychopharmacology 12, 46-46.

Curran HV (1998) . Future perspectives: Psychlogical research on MDMA ('ecstasy'). Journal of Psycopharmacology 12, 101.

Curran HV (1998). Memory and Pharmacology. Journal of Neurology 87, 76.

Curran HV (1998). Moody blues: the mental health effects of ecstasy (MDMA)Open Mind (93), 14-16.

Curran HV (1998) Psychopharmacological Insights on Memory Systems. Neurology 53, 14

Curran HV (1998). The effects of Anxiolytics on Memory in Hindmarch, I. (ed.) Anxiety and Anxiolytic Drugs. Plenum Press.

Curran HV, Poovibunsuk P , Dalton J & Lader MH (1998). Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology 135, 27-36.

Fluck E, Fernandes C , File S, Curran,HV & Marshall J (1998) . The influence of alcoholism and cirrhosis on benzodiazepine receptor function. Pharmacology, Biochemistry and Behaviour 59, 949-954.

Verheyden S, Curran HV (1998). Implications of MDMA use for mental health. Journal of Psychopharmacology 12, 48-48.

Back to top


Curran HV (1997) . Future perspectives on psychological research with MDMA ("Ecstasy") Proceedings of the British Psychological Society (5), 123-123.

Curran HV (1997) Future perspectives for psychological research with MDMA ('ecstasy'). Journal of Psychopharmacology, 12, 101.

Curran HV (1997). Psychopharmacological perspectives on memory. Brain and Cognition (35), 289-290.

Curran HV, Charles, C (1997). Residual effects of MDMA on mood and cognitive function. Journal of Psychopharmacology (11), 84-84.

Curran HV, Travill RA (1997) . Mood and cognitive effects of MDMA: Mid-week low after week-end high. Journal of Psychopharmacology (11), 84-84.

Curran HV, Travill RA (1997). Mood and cognitive effects of Methylenedioxymethamphetamine (MDMA, "Ecstasy"): week-end "high" followed by mid-week "low". Addiction (92), 821-831.

Curran, HV (1997). Future perspectives for psychological research with MDMA ('ecstasy') Journal of Psychopharmacology 12, 101.

Kopelman MD, Curran HV (1997). Reviewing the Cognitive Psychopharmacology of Alzheimer's Disease in Vellas,B. (ed.) Interventional and Therapeutic Studies in Alzheimer's Disease. New York: Springer.

Back to top


Bishop K, Curran HV, Lader MH (1996). Do scopolamine and lorazepam have dissociable effects upon human memory systems? A dose-response study with normal volunteers. Experimental and Clinical Psychopharmacology, 6, 292 - 299.

Curran HV, Kopelman, MD (1996). The Cognitive Psychopharmacology of Alzheimer's Disease. in Morris,R.G. (ed.) The Cognitive Neuropsychology of Alzheimer's Disease. Oxford: Oxford University Press, 255-277.

Curran HV (1996). State-dependency in humans: drug and mood effects revisited. Pharmacology 7, 22.

Curran HV (1996). Why do benzodiazepines induce amnesia? European Journal of Neuroscience S9, 20.

Kapczinski F, Curran HV, Przemioslo R, Williams R, Fluck E, Fernandes C, File S (1996). Cognitive impairments of alcoholic cirrhotic patients correlate with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors. Journal of Neurology, Neurosurgery and Psychiatry 60, 676-680.

Pompeia S, Gorenstein C, Curran HV (1996). Benzodiazepine effects on memory tests: dependence on retrieval cues? International Clinical Psychopharmacology 11(4), 229-236.

Pompeia S, Gorenstein C, Curran HV (1996). Does potency determine the amnestic effects of benzodiazepines? A dose-response comparison of flunitrazepam and nitrazepam. Behavioural Pharmacology 7, 532-539.

Poovibunsuk P, Dalton J, Curran HV & Lader MH (1996). The effects of single doses of lorazepam on event-related potentials and cognitive function. Human Psychopharmacology 11, 241-252.

Back to top


Bishop KI, Curran,HV (1995). Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepines antagonist, flumazenil. Psychopharmacology 121, 267-278.

Bond A, Curran HV, Bruce M,O'Sullivan G & Shine P (1995). Behavioural aggression in panic disorder after 8 weeks treatment with alprazolam. Journal of Affective Disorders 35, 117-123.

Curran HV, Barrow S, Weingartner HJ, Bernik M (1995). Encoding, remembering and awareness in lorazepam-induced amnesia. Psychopharmacology 122, 187-193.

Curran HV, Tulving, E (1995). Recollection of Events, Memory for Facts and 'False' memories: a study with lorazepam. Journal of Psychopharmacology 9S, 53; A15.

Kapczinski F, Sherman D, Williams R, Lader MH & Curran HV (1995). Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients. Psychopharmacology 120, 220-226.

Pompeia S, Gorenstein C, Curran, HV (1995). Differential amnestic and sedative effects of flunitrazepam and nitrazepam in healthy volunteers. Journal of Psychopharmacology 9S, A14; 53.

Weingartner HJ, Sirocco K, Curran HV & Wolkowitz O (1995). Memory facilitation following the administration of the benzodiazepine triazolam. Experimental and Clinical Psychopharmacology 3, 298-303.

Back to top